Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ma, yujuan
IMM01-02, NCT05140811: A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome	Recruiting	1/2	126	RoW	IMM01, IMM01 Ingection, Azacitidine, Vidaza	ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Institute of Hematology & Blood Diseases Hospital	Acute Myeloid Leukemia, Myelodysplastic Syndromes	02/24	03/24